Aveanna Healthcare to Release Q3 Results on Nov 6, 2025, with Conference Call

• Aveanna Healthcare will release Q3 results before the market open on Nov 6, 2025.

• Conference call to follow at 10:00 a.m. ET.

• Dial 1-877-407-0789 or 1-201-689-8562 for the call.

• Replay available until Nov 13, 2025.

• Webcast available on Aveanna's website.

Investors and financial professionals are eagerly awaiting the release of Aveanna Healthcare Holdings, Inc. (AVAH) Q3 results, which will be announced before the market opens on November 6, 2025. Following the earnings report, a conference call is scheduled at 10:00 a.m. ET, providing investors with an opportunity to discuss the company's performance. The call can be accessed by dialing 1-877-407-0789 or 1-201-689-8562. A replay of the call will be available until November 13, 2025, and a webcast will be available on Aveanna's website.

AVAH has been a strong performer in recent months, with shares up 13.2% over the past month and hitting a new 52-week high of $9.36. The company has also shown impressive earnings surprises, missing the consensus estimate in none of the last four quarters. In its most recent earnings report on August 7, 2025, AVAH reported earnings per share (EPS) of $0.18, exceeding the consensus estimate of $0.04. The company also beat the consensus revenue estimate by 9.93%, according to a Yahoo Finance report.

For the current fiscal year, AVAH is expected to post earnings of $0.41 per share on $2.31 in revenues, representing a significant change in EPS and revenues. For the next fiscal year, the company is expected to earn $0.48 per share on $2.47 in revenues, indicating a steady growth trend. Valuation metrics show that while AVAH has recently hit a 52-week high, it may have room to run. The company has a Value Score of B, a Growth Score of A, and a Momentum Score of F, giving it a VGM Score of B. The stock currently trades at 22.5X current fiscal year EPS estimates, a premium to the industry average of 21.2X, as noted in the Yahoo Finance report.

AVAH's strong performance stands out in the Medical - Outpatient and Home Healthcare industry, which is in the top 11% of all industries. One industry peer, U.S. Physical Therapy, Inc. (USPH), also showed strong performance, with a Zacks Rank of #2 (Buy) and a Value Score of C, a Growth Score of B, and a Momentum Score of C. USPH beat consensus estimates and has gained 16% over the past month, according to the same Yahoo Finance coverage.

Investors are encouraged to monitor the earnings release and the subsequent conference call to gain insights into AVAH's Q3 performance and future prospects.